Skip to content

Cradle vs Insilico Medicine

A side-by-side comparison of Cradle and Insilico Medicine, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

Cradle

Science

AI protein-engineering platform for faster lab design rounds.

View Cradle

Insilico Medicine

Science

Generative AI drug discovery — the end-to-end Pharma.ai suite.

View Insilico Medicine

At a glance

Feature comparison of Cradle and Insilico Medicine
AttributeCradleInsilico Medicine
CategoryScienceScience
PricingPAIDPAID
LicenseProprietaryProprietary
DeploymentCloudCloud
Platforms (differs)WebWeb, API
Model support (differs)—Self-contained (on-device)
Vendor (differs)CradleInsilico Medicine

The honest brief

Cradle

Self-serve web SaaS for protein engineering with per-customer models and an in-house wet lab — a usable product where most rivals are partnership-only.

  • Self-serve web platform
  • Multi-property optimization
  • Per-customer models on your lab data
  • Customers keep IP, no royalties
  • Enterprise sales-led pricing
  • No public free tier
  • Needs customer wet-lab data
  • Not a downloadable model

Insilico Medicine

Sells its full discovery pipeline as licensed software — pharma can run PandaOmics and Chemistry42 directly, not just via a partner-only program.

  • End-to-end Pharma.ai software suite
  • Used by most of the top-20 pharma
  • First AI-designed drug into Phase 2
  • $2.75B Eli Lilly partnership
  • Enterprise-only, opaque pricing
  • Built for pharma R&D, not general users
  • No approved drug yet
  • Heavy domain expertise required
Cradle detailsInsilico Medicine detailsAll Science apps